Trevena, Inc. (NASDAQ: TRVN) is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders. Trevena’s novel pipeline includes product candidates aimed at moderate-to-severe acute pain, migraine, opioid use disorder, and other CNS indications. All of the company’s assets have unique mechanisms of action (MOA) that are designed to o...
Trevena, Inc. (NASDAQ: TRVN) is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders. Trevena’s novel pipeline includes product candidates aimed at moderate-to-severe acute pain, migraine, opioid use disorder, and other CNS indications. All of the company’s assets have unique mechanisms of action (MOA) that are designed to optimize receptor pharmacology. Trevena’s novel pipeline includes product candidates aimed at moderate-to-severe acute pain, migraine, opioid use disorder, and other CNS indications.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.